Maravai LifeSciences Holdings, Inc. MRVI Asia Pacific — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s asia pacific — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s asia pacific — revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported asia pacific — revenue of $7.87M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s asia pacific — revenue changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s asia pacific — revenue decreased by 25.4% year-over-year, from $10.56M to $7.87M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s asia pacific — revenue?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s asia pacific — revenue has grown at a -16.1% compound annual growth rate (CAGR), from $83.65M to $41.47M.
- What does asia pacific — revenue mean?
- This metric represents the total gross sales generated from customers located within the Asia Pacific geographic region. It reflects the company's market penetration and demand for nucleic acid production and biologics safety testing services in this specific territory. Monitoring this figure helps investors assess regional growth trends and the effectiveness of international commercial expansion strategies.